People’s expectations influence microdosing outcomes, Canadians sue government for psilocybin access, and a post-mortem on the DEA’s canceled tryptamine ban
DEA abandons plan to prohibit more psychedelics, Colorado to vote on psychedelics in November, APA says science to support psychedelic treatment is “inadequate”